A physiologically based pharmacokinetic model of voriconazole integrating time-dependent inhibition of CYP3A4, genetic polymorph
![Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology](https://www.futuremedicine.com/cms/10.2217/17460913.1.4.365/asset/images/medium/graphic35.gif)
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig7_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
![Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information | npj Digital Medicine Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-022-00639-0/MediaObjects/41746_2022_639_Fig1_HTML.png)
Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information | npj Digital Medicine
Voriconazole–Cyclodextrin Supramolecular Ternary Complex-Loaded Ocular Films for Management of Fungal Keratitis | Molecular Pharmaceutics
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig1_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
![Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00331/article_deploy/html/images/pharmaceutics-13-00331-g001.png)
Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network
![Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology](https://www.futuremedicine.com/cms/10.2217/17460913.1.4.365/asset/images/medium/graphic36.gif)
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig6_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
![The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review - Li - 2017 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review - Li - 2017 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0f0c05be-b6db-40db-a629-b89094b1a2bb/jcpt12493-toc-0001-m.jpg?trick=1666640801757)